Last Updated: July 22, 2026

DAPIPRAZOLE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Dapiprazole, and what generic alternatives are available?

Dapiprazole is a drug marketed by Baradaina Llc and Fera Pharms and is included in two NDAs.

The generic ingredient in DAPIPRAZOLE is dapiprazole hydrochloride. There are two drug master file entries for this compound. Additional details are available on the dapiprazole hydrochloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for DAPIPRAZOLE?
  • What are the global sales for DAPIPRAZOLE?
  • What is Average Wholesale Price for DAPIPRAZOLE?
Summary for DAPIPRAZOLE
US Patents:0
Applicants:2
NDAs:2
DailyMed Link:DAPIPRAZOLE at DailyMed

US Patents and Regulatory Information for DAPIPRAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baradaina Llc DAPIPRAZOLE HYDROCHLORIDE dapiprazole hydrochloride SOLUTION/DROPS;OPHTHALMIC 204902-001 May 30, 2019 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Fera Pharms DAPIPRAZOLE HYDROCHLORIDE dapiprazole hydrochloride SOLUTION/DROPS;OPHTHALMIC 019849-001 Dec 31, 1990 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.